Post-cycle therapy (PCT) without monitoring is guesswork. Bloodwork at 6–8 weeks post-cycle confirms whether HPTA recovery is occurring, whether organ function has normalized, and whether cardiovascular markers are returning to baseline — allowing informed decisions about future cycles or TRT transition.
Test LH, FSH, and total testosterone at 6–8 weeks post-cycle to confirm natural testosterone production is recovering
Lipid panel should normalize within 6–12 weeks — persistent HDL suppression after 12 weeks suggests structural lipid dysregulation
Liver enzymes (AST, ALT) from oral AAS should normalize within 4–8 weeks post-cycle
Hematocrit takes 8–16 weeks to normalize — test before starting another cycle or donating blood
If LH and FSH remain suppressed at 12 weeks post-PCT, referral to an endocrinologist is warranted to evaluate hypogonadism
Give your clients professional bloodwork analysis with TRT-specific reference ranges, longitudinal trend tracking, and structured harm reduction insights — all under your coaching umbrella.
GearCheck provides blood marker analysis and harm reduction education. Information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional.